Bayer Sues J&J Over Alleged False Cancer Drug Claims
Johnson & Johnson is leaning on a flawed study to advertise its prostate cancer drug as having lower risk of death compared with Bayer's medication, alleged a New York federal lawsuit...To view the full article, register now.
Already a subscriber? Click here to view full article